A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

NCT05955261 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

70

Enrollment

OTHER

Sponsor class

Stopped PI requests voluntary hold

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Cytarabine
DRUG: Gemtuzumab Ozogamicin
DRUG: Daunorubicin Hydrochloride
DRUG: Fludarabine Phosphate
DRUG: Idarubicin Hydrochloride
DRUG: Mitoxantrone Hydrochloride
DRUG: Etoposide
DRUG: Gilteritinib

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]